Tribun Health Expands into Australia with CaloPix Registration

PARIS, October 6, 2026 /CourierPR/ -- Tribun Health, a global provider of digital pathology solutions, has expanded its operations into the Australian market, marking a significant step in the company's international growth strategy. The digital pathology platform, CaloPix® 6.2.0, has been registered as a Class 1 software IVD medical device in the Australian Register of Therapeutic Goods (ARTG No. 531926), enabling Tribun Health to offer its services to Australian pathology organizations.

CaloPix® is a web-based software designed for viewing, interpreting, and managing digital images of pathological glass slides. Its primary purpose is to support pathologists in the review, interpretation, and management of whole slide images (WSIs) for primary diagnosis. This registration is a crucial milestone for Tribun Health, as it allows the company to engage with Australian pathology networks and help them digitize their diagnostic workflows.

The CaloPix® platform provides a centralized environment for viewing, storing, retrieving, analyzing, annotating, and sharing digital pathology images. Its open architecture is designed to integrate with the broader pathology ecosystem, including scanners, laboratory information systems, storage infrastructure, and third-party artificial intelligence applications. This integration capability is crucial for Australian pathology organizations, which are increasingly looking for enterprise digital pathology environments that can connect people, systems, images, and AI.

Tribun Health's CaloPix® platform has been recognized for its quality and performance, earning Best in KLAS honors for three consecutive years (2022-2024) and maintaining a top-tier ranking in 2025 and 2026. This recognition underscores the company's commitment to delivering high-quality digital pathology solutions that meet the needs of its customers.

With the registration of CaloPix® 6.2.0 in the ARTG, Tribun Health is well-positioned to support the digital transformation of pathology services in Australia, providing a robust platform for pathologists and laboratories to enhance their diagnostic capabilities and improve patient care.